Bangor Savings Bank »

Brainstorm Cell Therapeutics shares owned by Bangor Savings Bank

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Bangor Savings Bank from 13F filings

Historical chart of Bangor Savings Bank investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Bangor Savings Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Bangor Savings Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $188 266 0.71
2025-06-30 $297 266 1.12
2025-03-31 $335 266 1.26

More positions owned by Bangor Savings Bank

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
World Gold Tr Spdr Gld Minis (GLDM)
Ishares Tr Mbs Etf (MBB)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Bangor Savings Bank

Top funds holding Brainstorm Cell Therapeutics

Morgan Stanley
Advisor Group Holdings
Bangor Savings Bank
VSM Wealth Advisory
Steward Partners Investment Advisory
D. J. St. Germain

View all funds holding Brainstorm Cell Therapeutics